Maravai LifeSciences Holdings, Inc. (MRVI) stock
MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.38+0.10 (+1.37%)
Close on Nov 18, 2026Market cap $1.92BP/E –Yield –
Maravai LifeSciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Maravai LifeSciences's pe ratio was 116.0× on Jan 31, 2024, against 9.2× a year earlier. Over the last 2 years it ranged from 8.3× to 131.0×, with a median of 15.6×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 116.0× | −15.0 |
| 2023 | Dec 29, 2023 | 131.0× | +122.0 |
| 2022 | Dec 30, 2022 | 9.0× | – |
See a number that looks wrong?